Advertisement

Topics

[Comment] Immune checkpoint blockade for treating progressive multifocal leukoencephalopathy

21:21 EDT 16 May 2019 | The Lancet

A case series from the National Institutes of Health1 and two single case-reports2,3 indicate that some cases of progressive multifocal leukoencephalomyelopathy (PML) can benefit from treatment with pembrolizumab or nivolumab, which are anti-programmed death protein 1 (PD-1) checkpoint-blocking antibodies.

Original Article: [Comment] Immune checkpoint blockade for treating progressive multifocal leukoencephalopathy

NEXT ARTICLE

More From BioPortfolio on "[Comment] Immune checkpoint blockade for treating progressive multifocal leukoencephalopathy"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...